Intranasal nanotherapeutics for brain targeting and clinical studies in Parkinson's disease
Parkinson's disease (PD) is the second leading neurodegenerative disease globally,
impacting the quality of life of millions of people. It is estimated that the treatment cost of PD …
impacting the quality of life of millions of people. It is estimated that the treatment cost of PD …
Mechanistic approaches to predicting oral drug absorption
Modeling and simulation of oral drug absorption have been widely used in drug discovery,
development, and regulation. Predictive absorption models are used to determine the rate …
development, and regulation. Predictive absorption models are used to determine the rate …
[图书][B] Controlled drug delivery: fundamentals and applications
J Robinson, VHL Lee - 1987 - api.taylorfrancis.com
Controlled Drug Delivery Page 1 Controlled Drug Delivery Page 2 DRUGS AND THE
PHARMACEUTICAL SCIENCES A Series of Textbooks and Monographs Edited by James …
PHARMACEUTICAL SCIENCES A Series of Textbooks and Monographs Edited by James …
[HTML][HTML] Understanding the hysteresis loop conundrum in pharmacokinetic/pharmacodynamic relationships
Hysteresis loops are phenomena that sometimes are encountered in the analysis of
pharmacokinetic and pharmacodynamic relationships spanning from pre-clinical to clinical …
pharmacokinetic and pharmacodynamic relationships spanning from pre-clinical to clinical …
Evaluation of rat intestinal absorption data and correlation with human intestinal absorption
YH Zhao, MH Abraham, J Le, A Hersey… - European journal of …, 2003 - Elsevier
The absorption of 111 drug and drug-like compounds was evaluated from 111 references
based on the ratio of urinary excretion of drugs following oral and intravenous administration …
based on the ratio of urinary excretion of drugs following oral and intravenous administration …
Physiological manifestations of endophyte toxicosis in ruminant and laboratory species
JW Oliver - Neotyphodium/grass interactions, 1997 - Springer
Fescue alkaloid intake by cattle results in adverse metabolic effects that cause billion dollar
losses annually to livestock production in the US alone (Bacon et al., 1977; Garner and …
losses annually to livestock production in the US alone (Bacon et al., 1977; Garner and …
Intracerebroventricular administration of bromocriptine ameliorates the insulin-resistant/glucose-intolerant state in hamsters
S Luo, Y Liang, AH Cincotta - Neuroendocrinology, 1999 - karger.com
Bromocriptine, a potent dopamine D 2 receptor agonist, suppresses lipogenesis and
improves glucose intolerance and insulin resistance. Recent evidence suggests that …
improves glucose intolerance and insulin resistance. Recent evidence suggests that …
Interactions between the dopamine agonist, bromocriptine and the efflux protein, P-glycoprotein at the blood–brain barrier in the mouse
S Vautier, L Lacomblez, H Chacun, V Picard… - European journal of …, 2006 - Elsevier
Bromocriptin (BCT) is a dopaminergic receptor agonist, poorly transported through the blood–
brain barrier (BBB) and responsible for central side effects. Interactions between BCT and …
brain barrier (BBB) and responsible for central side effects. Interactions between BCT and …
Nanomedicine for Maternal and Fetal Health
Conception, pregnancy, and childbirth are complex processes that affect both mother and
fetus. Thus, it is perhaps not surprising that in the United States alone, roughly 11% of …
fetus. Thus, it is perhaps not surprising that in the United States alone, roughly 11% of …
Antiparkinsonian dopamine agonists: a review of the pharmacokinetics and neuropharmacology in animals and humans
H Wachtel - Journal of neural transmission-Parkinson's disease …, 1991 - Springer
With the intention of compensating for the deficit of endogenous dopamine (DA) in the basal
ganglia of Parkinsonian patients by substitution with agents which directly stimulate central …
ganglia of Parkinsonian patients by substitution with agents which directly stimulate central …